ArticleJournal of clinical laboratory analysis2026
Pediatric Systemic Lupus Erythematosus Complicated by Acute EBV and CMV Co-infection.
Article in Journal of clinical laboratory analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundSystemic lupus erythematosus (SLE) is a multifactorial autoimmune disease characterized by multi-organ damage, with genetic, environmental, and viral factors implicated in its pathogenesis. Herpesviruses such as Epstein-Barr virus (EBV) and cytomegalovirus (CMV) are known to trigger or exacerbate SLE, potentially through mechanisms like molecular mimicry and immune dysregulation. CASE PRESENTATION: We report the case of a 10-year-old girl who presented with a malar rash following sun exposure, accompanied by fever and arthritis. Laboratory investigations revealed the presence of multiple autoantibodies and serological evidence of active co-infection with both EBV and CMV. A diagnosis of SLE with mild activity was established. The patient received intravenous methylprednisolone, belimumab, and oral ganciclovir. This led to significant clinical improvement, including resolution of the facial rash and normalization of joint mobility. Follow-up assessments showed near-complete normalization of inflammatory markers and autoantibody titers. However, causality cannot be established from a single case, and proposed mechanisms remain hypotheses.
conclusionThis case suggests that acute co-infection with EBV and CMV may play a role in the pathogenesis of SLE, possibly via molecular mimicry and B-cell activation. Therefore, routine screening for EBV and CMV in adolescent SLE patients may be warranted to advance etiological research and inform personalized treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.